Two Sigma Advisers’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-511,043
Closed -$3.13M 156
2025
Q4
$3.13M Buy
511,043
+472,543
+1,227% +$5.1M 0.01% 1004
2025
Q3
$710K Sell
38,500
-10,000
-21% -$161K ﹤0.01% 1616
2025
Q2
$631K Buy
+48,500
New +$574K ﹤0.01% 1647
2021
Q3
Sell
-320,343
Closed -$10.8M 2433
2021
Q2
$10.8M Buy
320,343
+48,000
+18% +$1.62M 0.03% 536
2021
Q1
$11.2M Buy
272,343
+96,700
+55% +$5.76M 0.03% 530
2020
Q4
$7.62M Buy
175,643
+17,800
+11% +$1.21M 0.02% 662
2020
Q3
$6.77M Buy
157,843
+48,600
+44% +$2.41M 0.02% 661
2020
Q2
$5.11M Buy
109,243
+60,300
+123% +$2.08M 0.02% 784
2020
Q1
$665K Sell
48,943
-100
-0.2% -$1.28K ﹤0.01% 1673
2019
Q4
$533K Buy
+49,043
New +$513K ﹤0.01% 1854

Other funds holding ARCT